CUAMC
China Universal Asset Management Company Portfolio holdings
AUM
$1.06B
1-Year Return
31.81%
This Quarter Return
+22.53%
1 Year Return
+31.81%
3 Year Return
+205.04%
5 Year Return
–
10 Year Return
–
AUM
$295M
AUM Growth
+$46.7M
(+19%)
Cap. Flow
+$10.2M
Cap. Flow
% of AUM
3.44%
Top 10 Holdings %
Top 10 Hldgs %
32.39%
Holding
456
New
65
Increased
317
Reduced
38
Closed
9
Top Buys
| 1 |
NVIDIA
NVDA
|
$7.81M |
| 2 |
PayPal
PYPL
|
$4.77M |
| 3 |
STAAR Surgical
STAA
|
$3.64M |
| 4 |
Chipotle Mexican Grill
CMG
|
$3.46M |
| 5 |
Microsoft
MSFT
|
$3.33M |
Top Sells
| 1 |
iQIYI
IQ
|
$7.64M |
| 2 |
Pinduoduo
PDD
|
$6.59M |
| 3 |
ON Semiconductor
ON
|
$4.45M |
| 4 |
Apple
AAPL
|
$3.07M |
| 5 |
Rambus
RMBS
|
$2.77M |
Sector Composition
| 1 | Technology | 38.43% |
| 2 | Consumer Discretionary | 23.55% |
| 3 | Healthcare | 18.31% |
| 4 | Communication Services | 8.83% |
| 5 | Financials | 4.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
176
Axsome Therapeutics
AXSM
$6.25B
| $36.3K | 0.01% |
589
+148
| +34% | +$9.13K |
|
|
RVNC
177
DELISTED
Revance Therapeutics, Inc.
RVNC
| $36.1K | 0.01% |
1,122
+286
| +34% | +$9.21K |
|
178
Prothena Corp
PRTA
$460M
| $34.5K | 0.01% |
712
+221
| +45% | +$10.7K |
|
179
BridgeBio Pharma
BBIO
$10.2B
| $34K | 0.01% |
2,050
+531
| +35% | +$8.8K |
|
|
SAGE
180
DELISTED
Sage Therapeutics
SAGE
| $33.9K | 0.01% |
809
+204
| +34% | +$8.56K |
|
181
Insmed
INSM
$30.7B
| $31.5K | 0.01% |
1,848
+472
| +34% | +$8.05K |
|
182
Applied Materials
AMAT
$130B
| $31.4K | 0.01% |
+256
| New | +$31.4K |
|
183
Zai Lab
ZLAB
$3.42B
| $31.4K | 0.01% |
945
+244
| +35% | +$8.12K |
|
184
Xenon Pharmaceuticals
XENE
$3.02B
| $30.4K | 0.01% |
848
+213
| +34% | +$7.62K |
|
185
AbCellera Biologics
ABCL
$1.26B
| $29.4K | 0.01% |
3,898
+992
| +34% | +$7.48K |
|
|
MRTX
186
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $29.2K | 0.01% |
786
+201
| +34% | +$7.47K |
|
187
Mondelez International
MDLZ
$79.9B
| $28.7K | 0.01% |
+412
| New | +$28.7K |
|
|
PRVB
188
DELISTED
Provention Bio, Inc. Common Stock
PRVB
| $28.5K | 0.01% |
1,181
+295
| +33% | +$7.11K |
|
189
Krystal Biotech
KRYS
$4.35B
| $27.9K | 0.01% |
349
+87
| +33% | +$6.97K |
|
190
Automatic Data Processing
ADP
$120B
| $27.8K | 0.01% |
+125
| New | +$27.8K |
|
191
Immunovant
IMVT
$2.99B
| $27.4K | 0.01% |
1,764
+452
| +34% | +$7.01K |
|
192
Relay Therapeutics
RLAY
$710M
| $27.1K | 0.01% |
1,644
+416
| +34% | +$6.85K |
|
193
Supernus Pharmaceuticals
SUPN
$2.58B
| $26.6K | 0.01% |
733
+184
| +34% | +$6.67K |
|
194
Revolution Medicines
RVMD
$7.57B
| $26.6K | 0.01% |
1,226
+324
| +36% | +$7.02K |
|
195
Harmony Biosciences
HRMY
$2.07B
| $26.3K | 0.01% |
807
+204
| +34% | +$6.66K |
|
196
Amylyx Pharmaceuticals
AMLX
$910M
| $26.3K | 0.01% |
897
+224
| +33% | +$6.57K |
|
197
Ventyx Biosciences
VTYX
$180M
| $25.7K | 0.01% |
767
+192
| +33% | +$6.43K |
|
198
Myriad Genetics
MYGN
$615M
| $25.5K | 0.01% |
1,098
+275
| +33% | +$6.39K |
|
199
Pacira BioSciences
PCRX
$1.19B
| $25.4K | 0.01% |
623
+157
| +34% | +$6.41K |
|
200
Maravai LifeSciences
MRVI
$363M
| $25K | 0.01% |
1,786
+450
| +34% | +$6.31K |
|